SlideShare a Scribd company logo
ANTIBIOTICSIN
SURGERY
Prof. Dr. Senthil Kumar
OUTLINE
• Introduction
• Antibiotics Classification
• Usesof Antibiotics in Surgery
• Prophylaxis
• Therapeutic
ANTIBIOTICS: a natural substance produced by a micro-organism to
kill another.
• They include the culture extracts and filtrates of fungi such as
penicillium and cephalosporium and bacteria such as streptomyces
and bacillus species.
ANTIMICROBIAL: any natural or synthetic agent that kills
pathogens
• They include the sulfonamides, trimethoprim, cotrimoxazole,
nitrofurantoin, nalidixic acid, metroniadazole, P.aminosalicylic
acid, isoniazid and ethambutol.
• Antifungal agents include nystatin, and flucytosine.
NORMALFLORA
Mechanism of Action
• Inhibition of Cell Wall Synthesis
• Disruption of Cell Membrane
• Inhibition of Protein Synthesis
• Inhibition of Nucleic acid synthesis
• Interference with Metabolic Processes
ANTIBIOTICSCLASSIFICATION
Cell wall synthesis inhibitors
• Beta-lactams
• Poly-peptides
Protein synthesis inhibitors
• Aminoglycosides
• Tetracyclins
• Macrolides
• Chloramphenicol
• Clindamycin
Folate antagonists
• Sulfonamides
• Trimethoprim
• Quinolones
Beta-lactams Poly-peptides
Classification
Cell wall synthesis inhibitors
Penicillins
Cephalosporin
Monobactam (Aztreonam)
Carabpenems
(Meropenem/Imipenem)
Bacitracin
Vancomycin
Cell wall synthesis inhibitors
Penicillins Cephalosporins
Beta lactams
Narrow spectrum – penicillinase sensitive
Benzylpenicillin, Phenoxymethylpenicillin
Narrow spectrum – penicillinase resistant
Methicillin, Oxacillin, Cloxacillin, Dicloxacillin
Broad spectrum penicillins
Ampicillin, Amoxicillin
Extended spectrum penicillins
Carbenicillin, Ticarcillin, Mezlocillin, Pipercillin
First generation –
β-lactamase sensitive
Cephazolin, Cephalexin
Third generation – mostly
β-lactamase resistant
Cefotaxime, Ceftriaxone
Second generation – β-
lactamase sensitive
Cefaclor, Cefamanodole
Cefoxitin
Fourth generation – mostly
β-lactamase restistant
Cefepime, Cefpirome
Mechanism of action :
1. The β-lactam binds to Penicillin Binding
Protein (PBP)
2. PBP is unable to crosslink peptidoglycan
chains
3. The bacteria is unable to synthesize a stable
cell wall
4. The bacteria is lysed
Classification
Protein synthesis inhibitors
Aminoglycosides
Tetracyclines
Macrolides
Chloramphenicol
Clindamycin
Classification
Aminoglycosides
Protein synthesis inhibitors
• Gentamicin
• Tobramycin
• Streptomycin
• Neomycin
• Kanamycin
• Amikacin
Tetracyclines Macrolides
• Tetracycline
• Doxytetracycline
• Minocycline
• Doxycycline
• Erythromycin
• Azithromycin
• Clarithromycin
Classification
Sulfonamide
Folate antagonist
• Sulfadiazine
• Sulfadimidine
• Sulfamethoxazole
Quinolones Trimethoprim
• Nalidixic acid
• Ciprofloxacin
• Levofloxacin
• Ofloxacin
• Norfloxacin
• Travofloxacin
PrinciplesofAntibiotics in
Surgery
• Indication (prophylaxis vs.therapeutic)
• Susceptibility vs.empirical
• Pharmacokinetic
• Pharmacodynamics
• Combination ?
• Cost
• Availability
• Monitoring
• Compliance
Antibiotics Prophylaxis inSurgery
• Use of antibiotic where there is no evidence of infection
but expected to be exposed to pathogens that constitutes
a major risk of infection.
• Single dose regime, based on the most common organism,
which is given at the time of induction to ensure the minimum
inhibitory concentration during skin incision –reduces risk of
surgical site infection (SSI)and post op infection.
• Usually a single dose is sufficient. A second dose
may be required in the following situations:
a. in prolonged operations
b. when there is contamination during operation
• Giving more than 1 or 2 doses postoperatively is
generally not advised. The practice of continuing
prophylactic antibiotics until surgical drains have
been removed is not recommended.
General Principles ofSurgical
Prophylaxis
• A single preoperative dose of antibiotic is as effective as
full five days course of therapy assuming uncomplicated
procedure.
• Prophylactic antibiotics should be administered within 1
hour prior to incision, preferably with induction of
anesthesia.
• Prophylactic antibiotics should targetanticipated
organisms.
• Prophylaxis is generally recommended for clean-
contaminated (risk of infection is 6%) and
contaminated (risk of infection is 15%)
operations.
• In clean operation prophylaxis is also indicated under
certain conditions i.e. where there is prosthesis
implanted, high risk perforation where infection is
catastrophic e.g. neurosurgery or cardiac surgery.
Classificationof SurgicalWound
GoalsofAntibiotic Prophylaxis
• Reducethe incidence of surgical site infection (SSI)
• Minimize the effect on the patient’s normal bacterial
flora.
• Minimize adverse side effects of antibiotics.
• Minimize the emergence of antibiotics resistant strains of
bacteria.
• Costeffectiveness.
PROCEDURE SUGGESTED ANTIBIOTIC
1. GI surgery
2. HBS surgery
IV Cefoperazone 1g PLUS IV
Metronidazole 500mg
1.Hernia repair with mesh
(includes laparoscopic repair)
2. Breast
(not recommended for minor
excision
3.Burns
IV Cloxacillin 1G
Vascular Operation IV Ampicillin/Sulbactam 1.5g
Neurosurgery IV Ceftriaxone 1gm AND
IV Metronidazole 500mg
Urology IV Amoxicillin / clavulanate 1.2g
GUIDELINES FOR SURGICAL
PROPHYLACTICANTIBIOTICS
THERAPEUTIC ANTIBIOTICS
Therapeutic
Antibiotics:
PRINCIPLES
C&S
Pharmaco-
dynamics&
TDM
Hoststatus
Site of
infection
Combination
Prevent
resistance
Synergism/
Additive
therapy
Multiple
pathogens
THERAPEUTIC
ANTIBIOTICS
Empirical
Initiation of treatment
prior to determination of a
firm diagnosis
Definitive
Specific toorganism isolated
inC&S
EMPIRIC THERAPY
• When to start?
• Riskof surgicalinfection is high - basedon the underlying disease
process(e.g.perforated appendicitis)[prophylaxis  empiric]
• Significant contamination during surgeryhasoccurred(e.g.
considerablespillageof colon contents)
• In critically ill patients –potential site of infection hasbeenidentified
• Severe sepsisor septicshock
• Short course (3-5days)
• Stop if the presence of alocal site or systemic infection is not
revealed.
MONOMICROBIALVS
POLYMICROBIAL
• Monomicrobial infections:
• Nosocomialwhich occurredin postoperative patients, e.g.UTI,
pneumonia, catheter-relatedinfection
• Polymicrobial infections:
culture results lesshelpful
• Thus,antibiotic regimen should not be modified solely on
culture information. Clinical course is moreimportant.
Systemic InflammatoryResponse
Syndrome(SIRS)
• Empiric antibiotics are not indicated for all patients with
SIRS
• Indications for antibiotic therapy include the following:
• Suspected or diagnosedinfectious etiology (e.g.UTI,
pneumonia,cellulitis)
• Neutropenia or other immunocompromised states
• Asplenia- Dueto the potential for overwhelming
postsplenectomyinfection
• Abdominal trauma –3rd generationCephalosporins,
Cefuroxime, Augmentin,Unasyn
• Perforatedviscus,Peritonitis - 3rd generationCephalosporins
& Flagyl
• Breast abscess(S.aureus) –Cloxacillin
• Mycotic pseudoaneurysm –Cloxacillin
• Prostethic graft infection - 3rd generationCephalosporins
• MRSA-Vancomycin
DURATION OF THERAPY
• Duration should be long enough to prevent relapse
yet not excessive, asit canincrease side effects and
resistance.
• Factors suchasdecreasing trend ofWBCsand lack of
fever guide the length of therapy.
• The search for extra abdominal source of infection
or aresidual /ongoing source of intra abdominal
infectionshould be sought.
DURATION OFTHERAPY
• Penetrating GItrauma withoutextensive
contamination
• 12-24hours
• Perforated/gangrenous appendicitis
• 3-5days
• Peritoneal soilage due to perforated viscuswith
moderate degrees ofcontamination
• 5-7days
• Extensive peritoneal soilage/immunocompromised
host
• 7-14days
SIDE EFFECTS
Antibiotic Side Effects
Penicillins • Allergy (seriousanaphylaxis)
Cephalosporins • Allergy
Aminoglycosides • Hearing loss
• Vertigo
• Renaldysfunction
Carbapenems • Seizures(Imipenem)
• Rashes
Macrolides • Prolonged QTinterval
(Erythromycin)
• Hearing loss
• Jaundice
ANTIBIOTICRESISTANCE
• Resistance of amicroorganism to an
antimicrobial agent to which it was previously
sensitive.
• Resistant organisms are able to withstand attack
by antimicrobial medicines so that standard
treatments become ineffective and infections
persist and may spread to others
ANTIBIOTICRESISTANCE
Intrinsic
• Drug target is not present in the bacteria’s metabolic
pathways
Acquired
• Mutation
• Transferof genetic material from resistant to susceptible
organisms (plasmids, transposons,bacteriophages)
Main factors contributing to resistance are:
• Excessantibiotic usage
• Incorrect useof broad spectrum agents
• Incorrect dosing
• Noncompliance
Resistance to Antibiotics
• By genetic mutation — changes to the proteins and other
components of bacterial cells which Antimicrobial use as
binding sites (DRUG INACTIVATION OR
MODIFICATION).
• Gene transfer: plasmids (via conjugation and
transduction);
• By bacteria producing enzymes (β-lactamase) that destroy or
inactivate Antimicrobial.
• Microbes may cease active uptake of certain
Resistance to Antibiotics
• Changes in receptors which decrease antibiotic binding and
action : ALTERATION OF TARGET OR BINDING SITE
OF ANTIBIOTICS)
• Microbes may synthesize compounds that antagonize drug
actions.
• By bacteria altering the permeability of their cell membrane
making it difficult for Antimicrobial to enter (ACTIVE
EFFLUX).
• Antibiotic use promotes the emergence of drug-resistant
microbes.
THANKYOU

More Related Content

Similar to 6949_antibioticinsurgery.pptx

Prinicple of Anti microbial therapy dr.kanwar singh.ppt
Prinicple of Anti microbial therapy dr.kanwar singh.pptPrinicple of Anti microbial therapy dr.kanwar singh.ppt
Prinicple of Anti microbial therapy dr.kanwar singh.ppt
UnnayanRaj
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
Walahassan4
 
Antibiotics 150406092448-conversion-gate01
Antibiotics 150406092448-conversion-gate01Antibiotics 150406092448-conversion-gate01
Antibiotics 150406092448-conversion-gate01Mostafa Abd El Fattah
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
Mohammed Ezz El-din
 
Therapeutics in dentistry (antibiotics)
Therapeutics in dentistry (antibiotics)Therapeutics in dentistry (antibiotics)
Therapeutics in dentistry (antibiotics)Iyad Abou Rabii
 
presentation.pptx
presentation.pptxpresentation.pptx
presentation.pptx
kiogakimathi
 
Antibiotics by DR: ABBAS ALI SHAH
Antibiotics by DR: ABBAS ALI SHAH Antibiotics by DR: ABBAS ALI SHAH
Antibiotics by DR: ABBAS ALI SHAH
AjazAttari1
 
Principle of antibiotic prophylaxis
Principle of antibiotic prophylaxisPrinciple of antibiotic prophylaxis
Principle of antibiotic prophylaxis
Hidayat Shariff
 
Rational use of antibiotics
Rational use of antibioticsRational use of antibiotics
Rational use of antibiotics
ZeelNaik2
 
Antibiotic policy
Antibiotic policyAntibiotic policy
Antibiotic policy
Dr. Md Ashraf Ali Namaji
 
AMA-_Antimicrobials_Intro.pdf
AMA-_Antimicrobials_Intro.pdfAMA-_Antimicrobials_Intro.pdf
AMA-_Antimicrobials_Intro.pdf
SanjayaManiDixit
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
Krishna Gandhi
 
ANTIBIOTICS IN SURGERY.pptx
ANTIBIOTICS IN SURGERY.pptxANTIBIOTICS IN SURGERY.pptx
ANTIBIOTICS IN SURGERY.pptx
AyozieNnamdi
 
Pharmacotherapy in Periodontology.ppt
Pharmacotherapy in Periodontology.pptPharmacotherapy in Periodontology.ppt
Pharmacotherapy in Periodontology.ppt
Dr Saif khan
 
antibiotics.pptx
antibiotics.pptxantibiotics.pptx
antibiotics.pptx
Krishna Gandhi
 
Chemotherapy in periodontology
Chemotherapy in periodontologyChemotherapy in periodontology
Chemotherapy in periodontology
Dr Saif khan
 
Drugs in perio
Drugs in perioDrugs in perio
Drugs in perio
Jeethu Jerry
 
Drugs in periodontics
Drugs in periodonticsDrugs in periodontics
Drugs in periodontics
Ananya Sharma
 
Antibiotics in maxillofacial infection
Antibiotics in maxillofacial  infectionAntibiotics in maxillofacial  infection
Antibiotics in maxillofacial infectionAlka Singh
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
Dr Revathy Mohan
 

Similar to 6949_antibioticinsurgery.pptx (20)

Prinicple of Anti microbial therapy dr.kanwar singh.ppt
Prinicple of Anti microbial therapy dr.kanwar singh.pptPrinicple of Anti microbial therapy dr.kanwar singh.ppt
Prinicple of Anti microbial therapy dr.kanwar singh.ppt
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
 
Antibiotics 150406092448-conversion-gate01
Antibiotics 150406092448-conversion-gate01Antibiotics 150406092448-conversion-gate01
Antibiotics 150406092448-conversion-gate01
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
 
Therapeutics in dentistry (antibiotics)
Therapeutics in dentistry (antibiotics)Therapeutics in dentistry (antibiotics)
Therapeutics in dentistry (antibiotics)
 
presentation.pptx
presentation.pptxpresentation.pptx
presentation.pptx
 
Antibiotics by DR: ABBAS ALI SHAH
Antibiotics by DR: ABBAS ALI SHAH Antibiotics by DR: ABBAS ALI SHAH
Antibiotics by DR: ABBAS ALI SHAH
 
Principle of antibiotic prophylaxis
Principle of antibiotic prophylaxisPrinciple of antibiotic prophylaxis
Principle of antibiotic prophylaxis
 
Rational use of antibiotics
Rational use of antibioticsRational use of antibiotics
Rational use of antibiotics
 
Antibiotic policy
Antibiotic policyAntibiotic policy
Antibiotic policy
 
AMA-_Antimicrobials_Intro.pdf
AMA-_Antimicrobials_Intro.pdfAMA-_Antimicrobials_Intro.pdf
AMA-_Antimicrobials_Intro.pdf
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
 
ANTIBIOTICS IN SURGERY.pptx
ANTIBIOTICS IN SURGERY.pptxANTIBIOTICS IN SURGERY.pptx
ANTIBIOTICS IN SURGERY.pptx
 
Pharmacotherapy in Periodontology.ppt
Pharmacotherapy in Periodontology.pptPharmacotherapy in Periodontology.ppt
Pharmacotherapy in Periodontology.ppt
 
antibiotics.pptx
antibiotics.pptxantibiotics.pptx
antibiotics.pptx
 
Chemotherapy in periodontology
Chemotherapy in periodontologyChemotherapy in periodontology
Chemotherapy in periodontology
 
Drugs in perio
Drugs in perioDrugs in perio
Drugs in perio
 
Drugs in periodontics
Drugs in periodonticsDrugs in periodontics
Drugs in periodontics
 
Antibiotics in maxillofacial infection
Antibiotics in maxillofacial  infectionAntibiotics in maxillofacial  infection
Antibiotics in maxillofacial infection
 
Antibiotics
AntibioticsAntibiotics
Antibiotics
 

More from Gokul Krishnan

14. Large Bowel, Rectum and Anus.pdf management
14. Large Bowel, Rectum and Anus.pdf management14. Large Bowel, Rectum and Anus.pdf management
14. Large Bowel, Rectum and Anus.pdf management
Gokul Krishnan
 
CYSTIC NEOPLASMS OF PANCREAScopy gokuy.pptx
CYSTIC NEOPLASMS OF PANCREAScopy gokuy.pptxCYSTIC NEOPLASMS OF PANCREAScopy gokuy.pptx
CYSTIC NEOPLASMS OF PANCREAScopy gokuy.pptx
Gokul Krishnan
 
BASIC SURGICAL SKILL AND ANASTOMOSES (2).pdf
BASIC SURGICAL SKILL AND ANASTOMOSES (2).pdfBASIC SURGICAL SKILL AND ANASTOMOSES (2).pdf
BASIC SURGICAL SKILL AND ANASTOMOSES (2).pdf
Gokul Krishnan
 
colorectalcancer-13139044522272-phpapp01-110821002819-phpapp01 (1).pptx
colorectalcancer-13139044522272-phpapp01-110821002819-phpapp01 (1).pptxcolorectalcancer-13139044522272-phpapp01-110821002819-phpapp01 (1).pptx
colorectalcancer-13139044522272-phpapp01-110821002819-phpapp01 (1).pptx
Gokul Krishnan
 
abdominoperinealresection-230308170906-3b30e42b (1).pptx
abdominoperinealresection-230308170906-3b30e42b (1).pptxabdominoperinealresection-230308170906-3b30e42b (1).pptx
abdominoperinealresection-230308170906-3b30e42b (1).pptx
Gokul Krishnan
 
acutecholecystitis-131207094939-phpapp02 (1).pptx
acutecholecystitis-131207094939-phpapp02 (1).pptxacutecholecystitis-131207094939-phpapp02 (1).pptx
acutecholecystitis-131207094939-phpapp02 (1).pptx
Gokul Krishnan
 
gravesdiseaseinchildren-140812071102-phpapp02.pptx
gravesdiseaseinchildren-140812071102-phpapp02.pptxgravesdiseaseinchildren-140812071102-phpapp02.pptx
gravesdiseaseinchildren-140812071102-phpapp02.pptx
Gokul Krishnan
 
preoperative-150906113327-lva1-app6891.pptx
preoperative-150906113327-lva1-app6891.pptxpreoperative-150906113327-lva1-app6891.pptx
preoperative-150906113327-lva1-app6891.pptx
Gokul Krishnan
 
chapter 10 skin and subcutaneous tissue (chapter 40 bailey ) (1).pptx
chapter 10 skin and subcutaneous tissue (chapter 40 bailey ) (1).pptxchapter 10 skin and subcutaneous tissue (chapter 40 bailey ) (1).pptx
chapter 10 skin and subcutaneous tissue (chapter 40 bailey ) (1).pptx
Gokul Krishnan
 
BENIGNPROSTATICHYPERPLASIA.pptx
BENIGNPROSTATICHYPERPLASIA.pptxBENIGNPROSTATICHYPERPLASIA.pptx
BENIGNPROSTATICHYPERPLASIA.pptx
Gokul Krishnan
 
fluidselectrolytes-171201061359.pptx
fluidselectrolytes-171201061359.pptxfluidselectrolytes-171201061359.pptx
fluidselectrolytes-171201061359.pptx
Gokul Krishnan
 
fluidselectrolytes-171201061359.pptx
fluidselectrolytes-171201061359.pptxfluidselectrolytes-171201061359.pptx
fluidselectrolytes-171201061359.pptx
Gokul Krishnan
 
11897_XRAYSINSTREUMENTSANDOPERATIVESURGERY (1).pptx
11897_XRAYSINSTREUMENTSANDOPERATIVESURGERY (1).pptx11897_XRAYSINSTREUMENTSANDOPERATIVESURGERY (1).pptx
11897_XRAYSINSTREUMENTSANDOPERATIVESURGERY (1).pptx
Gokul Krishnan
 
assessmentofmyocardialviability-190613040830.pptx
assessmentofmyocardialviability-190613040830.pptxassessmentofmyocardialviability-190613040830.pptx
assessmentofmyocardialviability-190613040830.pptx
Gokul Krishnan
 
maxillofacialtrauma-copy-150708102907-lva1-app6891.pdf
maxillofacialtrauma-copy-150708102907-lva1-app6891.pdfmaxillofacialtrauma-copy-150708102907-lva1-app6891.pdf
maxillofacialtrauma-copy-150708102907-lva1-app6891.pdf
Gokul Krishnan
 
headinjury-201024145340-converted.pptx
headinjury-201024145340-converted.pptxheadinjury-201024145340-converted.pptx
headinjury-201024145340-converted.pptx
Gokul Krishnan
 

More from Gokul Krishnan (16)

14. Large Bowel, Rectum and Anus.pdf management
14. Large Bowel, Rectum and Anus.pdf management14. Large Bowel, Rectum and Anus.pdf management
14. Large Bowel, Rectum and Anus.pdf management
 
CYSTIC NEOPLASMS OF PANCREAScopy gokuy.pptx
CYSTIC NEOPLASMS OF PANCREAScopy gokuy.pptxCYSTIC NEOPLASMS OF PANCREAScopy gokuy.pptx
CYSTIC NEOPLASMS OF PANCREAScopy gokuy.pptx
 
BASIC SURGICAL SKILL AND ANASTOMOSES (2).pdf
BASIC SURGICAL SKILL AND ANASTOMOSES (2).pdfBASIC SURGICAL SKILL AND ANASTOMOSES (2).pdf
BASIC SURGICAL SKILL AND ANASTOMOSES (2).pdf
 
colorectalcancer-13139044522272-phpapp01-110821002819-phpapp01 (1).pptx
colorectalcancer-13139044522272-phpapp01-110821002819-phpapp01 (1).pptxcolorectalcancer-13139044522272-phpapp01-110821002819-phpapp01 (1).pptx
colorectalcancer-13139044522272-phpapp01-110821002819-phpapp01 (1).pptx
 
abdominoperinealresection-230308170906-3b30e42b (1).pptx
abdominoperinealresection-230308170906-3b30e42b (1).pptxabdominoperinealresection-230308170906-3b30e42b (1).pptx
abdominoperinealresection-230308170906-3b30e42b (1).pptx
 
acutecholecystitis-131207094939-phpapp02 (1).pptx
acutecholecystitis-131207094939-phpapp02 (1).pptxacutecholecystitis-131207094939-phpapp02 (1).pptx
acutecholecystitis-131207094939-phpapp02 (1).pptx
 
gravesdiseaseinchildren-140812071102-phpapp02.pptx
gravesdiseaseinchildren-140812071102-phpapp02.pptxgravesdiseaseinchildren-140812071102-phpapp02.pptx
gravesdiseaseinchildren-140812071102-phpapp02.pptx
 
preoperative-150906113327-lva1-app6891.pptx
preoperative-150906113327-lva1-app6891.pptxpreoperative-150906113327-lva1-app6891.pptx
preoperative-150906113327-lva1-app6891.pptx
 
chapter 10 skin and subcutaneous tissue (chapter 40 bailey ) (1).pptx
chapter 10 skin and subcutaneous tissue (chapter 40 bailey ) (1).pptxchapter 10 skin and subcutaneous tissue (chapter 40 bailey ) (1).pptx
chapter 10 skin and subcutaneous tissue (chapter 40 bailey ) (1).pptx
 
BENIGNPROSTATICHYPERPLASIA.pptx
BENIGNPROSTATICHYPERPLASIA.pptxBENIGNPROSTATICHYPERPLASIA.pptx
BENIGNPROSTATICHYPERPLASIA.pptx
 
fluidselectrolytes-171201061359.pptx
fluidselectrolytes-171201061359.pptxfluidselectrolytes-171201061359.pptx
fluidselectrolytes-171201061359.pptx
 
fluidselectrolytes-171201061359.pptx
fluidselectrolytes-171201061359.pptxfluidselectrolytes-171201061359.pptx
fluidselectrolytes-171201061359.pptx
 
11897_XRAYSINSTREUMENTSANDOPERATIVESURGERY (1).pptx
11897_XRAYSINSTREUMENTSANDOPERATIVESURGERY (1).pptx11897_XRAYSINSTREUMENTSANDOPERATIVESURGERY (1).pptx
11897_XRAYSINSTREUMENTSANDOPERATIVESURGERY (1).pptx
 
assessmentofmyocardialviability-190613040830.pptx
assessmentofmyocardialviability-190613040830.pptxassessmentofmyocardialviability-190613040830.pptx
assessmentofmyocardialviability-190613040830.pptx
 
maxillofacialtrauma-copy-150708102907-lva1-app6891.pdf
maxillofacialtrauma-copy-150708102907-lva1-app6891.pdfmaxillofacialtrauma-copy-150708102907-lva1-app6891.pdf
maxillofacialtrauma-copy-150708102907-lva1-app6891.pdf
 
headinjury-201024145340-converted.pptx
headinjury-201024145340-converted.pptxheadinjury-201024145340-converted.pptx
headinjury-201024145340-converted.pptx
 

Recently uploaded

Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Dr KHALID B.M
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
DrSathishMS1
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 

Recently uploaded (20)

Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 

6949_antibioticinsurgery.pptx

  • 2. OUTLINE • Introduction • Antibiotics Classification • Usesof Antibiotics in Surgery • Prophylaxis • Therapeutic
  • 3. ANTIBIOTICS: a natural substance produced by a micro-organism to kill another. • They include the culture extracts and filtrates of fungi such as penicillium and cephalosporium and bacteria such as streptomyces and bacillus species.
  • 4. ANTIMICROBIAL: any natural or synthetic agent that kills pathogens • They include the sulfonamides, trimethoprim, cotrimoxazole, nitrofurantoin, nalidixic acid, metroniadazole, P.aminosalicylic acid, isoniazid and ethambutol. • Antifungal agents include nystatin, and flucytosine.
  • 6. Mechanism of Action • Inhibition of Cell Wall Synthesis • Disruption of Cell Membrane • Inhibition of Protein Synthesis • Inhibition of Nucleic acid synthesis • Interference with Metabolic Processes
  • 8. Cell wall synthesis inhibitors • Beta-lactams • Poly-peptides Protein synthesis inhibitors • Aminoglycosides • Tetracyclins • Macrolides • Chloramphenicol • Clindamycin Folate antagonists • Sulfonamides • Trimethoprim • Quinolones
  • 9. Beta-lactams Poly-peptides Classification Cell wall synthesis inhibitors Penicillins Cephalosporin Monobactam (Aztreonam) Carabpenems (Meropenem/Imipenem) Bacitracin Vancomycin
  • 10. Cell wall synthesis inhibitors Penicillins Cephalosporins Beta lactams Narrow spectrum – penicillinase sensitive Benzylpenicillin, Phenoxymethylpenicillin Narrow spectrum – penicillinase resistant Methicillin, Oxacillin, Cloxacillin, Dicloxacillin Broad spectrum penicillins Ampicillin, Amoxicillin Extended spectrum penicillins Carbenicillin, Ticarcillin, Mezlocillin, Pipercillin First generation – β-lactamase sensitive Cephazolin, Cephalexin Third generation – mostly β-lactamase resistant Cefotaxime, Ceftriaxone Second generation – β- lactamase sensitive Cefaclor, Cefamanodole Cefoxitin Fourth generation – mostly β-lactamase restistant Cefepime, Cefpirome
  • 11. Mechanism of action : 1. The β-lactam binds to Penicillin Binding Protein (PBP) 2. PBP is unable to crosslink peptidoglycan chains 3. The bacteria is unable to synthesize a stable cell wall 4. The bacteria is lysed
  • 13. Classification Aminoglycosides Protein synthesis inhibitors • Gentamicin • Tobramycin • Streptomycin • Neomycin • Kanamycin • Amikacin Tetracyclines Macrolides • Tetracycline • Doxytetracycline • Minocycline • Doxycycline • Erythromycin • Azithromycin • Clarithromycin
  • 14. Classification Sulfonamide Folate antagonist • Sulfadiazine • Sulfadimidine • Sulfamethoxazole Quinolones Trimethoprim • Nalidixic acid • Ciprofloxacin • Levofloxacin • Ofloxacin • Norfloxacin • Travofloxacin
  • 15.
  • 16. PrinciplesofAntibiotics in Surgery • Indication (prophylaxis vs.therapeutic) • Susceptibility vs.empirical • Pharmacokinetic • Pharmacodynamics • Combination ? • Cost • Availability • Monitoring • Compliance
  • 17. Antibiotics Prophylaxis inSurgery • Use of antibiotic where there is no evidence of infection but expected to be exposed to pathogens that constitutes a major risk of infection. • Single dose regime, based on the most common organism, which is given at the time of induction to ensure the minimum inhibitory concentration during skin incision –reduces risk of surgical site infection (SSI)and post op infection.
  • 18. • Usually a single dose is sufficient. A second dose may be required in the following situations: a. in prolonged operations b. when there is contamination during operation • Giving more than 1 or 2 doses postoperatively is generally not advised. The practice of continuing prophylactic antibiotics until surgical drains have been removed is not recommended.
  • 19. General Principles ofSurgical Prophylaxis • A single preoperative dose of antibiotic is as effective as full five days course of therapy assuming uncomplicated procedure. • Prophylactic antibiotics should be administered within 1 hour prior to incision, preferably with induction of anesthesia. • Prophylactic antibiotics should targetanticipated organisms.
  • 20. • Prophylaxis is generally recommended for clean- contaminated (risk of infection is 6%) and contaminated (risk of infection is 15%) operations. • In clean operation prophylaxis is also indicated under certain conditions i.e. where there is prosthesis implanted, high risk perforation where infection is catastrophic e.g. neurosurgery or cardiac surgery.
  • 22. GoalsofAntibiotic Prophylaxis • Reducethe incidence of surgical site infection (SSI) • Minimize the effect on the patient’s normal bacterial flora. • Minimize adverse side effects of antibiotics. • Minimize the emergence of antibiotics resistant strains of bacteria. • Costeffectiveness.
  • 23. PROCEDURE SUGGESTED ANTIBIOTIC 1. GI surgery 2. HBS surgery IV Cefoperazone 1g PLUS IV Metronidazole 500mg 1.Hernia repair with mesh (includes laparoscopic repair) 2. Breast (not recommended for minor excision 3.Burns IV Cloxacillin 1G Vascular Operation IV Ampicillin/Sulbactam 1.5g Neurosurgery IV Ceftriaxone 1gm AND IV Metronidazole 500mg Urology IV Amoxicillin / clavulanate 1.2g GUIDELINES FOR SURGICAL PROPHYLACTICANTIBIOTICS
  • 24.
  • 25.
  • 28. THERAPEUTIC ANTIBIOTICS Empirical Initiation of treatment prior to determination of a firm diagnosis Definitive Specific toorganism isolated inC&S
  • 29. EMPIRIC THERAPY • When to start? • Riskof surgicalinfection is high - basedon the underlying disease process(e.g.perforated appendicitis)[prophylaxis  empiric] • Significant contamination during surgeryhasoccurred(e.g. considerablespillageof colon contents) • In critically ill patients –potential site of infection hasbeenidentified • Severe sepsisor septicshock • Short course (3-5days) • Stop if the presence of alocal site or systemic infection is not revealed.
  • 30. MONOMICROBIALVS POLYMICROBIAL • Monomicrobial infections: • Nosocomialwhich occurredin postoperative patients, e.g.UTI, pneumonia, catheter-relatedinfection • Polymicrobial infections: culture results lesshelpful • Thus,antibiotic regimen should not be modified solely on culture information. Clinical course is moreimportant.
  • 31. Systemic InflammatoryResponse Syndrome(SIRS) • Empiric antibiotics are not indicated for all patients with SIRS • Indications for antibiotic therapy include the following: • Suspected or diagnosedinfectious etiology (e.g.UTI, pneumonia,cellulitis) • Neutropenia or other immunocompromised states • Asplenia- Dueto the potential for overwhelming postsplenectomyinfection
  • 32. • Abdominal trauma –3rd generationCephalosporins, Cefuroxime, Augmentin,Unasyn • Perforatedviscus,Peritonitis - 3rd generationCephalosporins & Flagyl • Breast abscess(S.aureus) –Cloxacillin • Mycotic pseudoaneurysm –Cloxacillin • Prostethic graft infection - 3rd generationCephalosporins • MRSA-Vancomycin
  • 33. DURATION OF THERAPY • Duration should be long enough to prevent relapse yet not excessive, asit canincrease side effects and resistance. • Factors suchasdecreasing trend ofWBCsand lack of fever guide the length of therapy. • The search for extra abdominal source of infection or aresidual /ongoing source of intra abdominal infectionshould be sought.
  • 34. DURATION OFTHERAPY • Penetrating GItrauma withoutextensive contamination • 12-24hours • Perforated/gangrenous appendicitis • 3-5days • Peritoneal soilage due to perforated viscuswith moderate degrees ofcontamination • 5-7days • Extensive peritoneal soilage/immunocompromised host • 7-14days
  • 35. SIDE EFFECTS Antibiotic Side Effects Penicillins • Allergy (seriousanaphylaxis) Cephalosporins • Allergy Aminoglycosides • Hearing loss • Vertigo • Renaldysfunction Carbapenems • Seizures(Imipenem) • Rashes Macrolides • Prolonged QTinterval (Erythromycin) • Hearing loss • Jaundice
  • 36. ANTIBIOTICRESISTANCE • Resistance of amicroorganism to an antimicrobial agent to which it was previously sensitive. • Resistant organisms are able to withstand attack by antimicrobial medicines so that standard treatments become ineffective and infections persist and may spread to others
  • 37. ANTIBIOTICRESISTANCE Intrinsic • Drug target is not present in the bacteria’s metabolic pathways Acquired • Mutation • Transferof genetic material from resistant to susceptible organisms (plasmids, transposons,bacteriophages)
  • 38. Main factors contributing to resistance are: • Excessantibiotic usage • Incorrect useof broad spectrum agents • Incorrect dosing • Noncompliance
  • 39. Resistance to Antibiotics • By genetic mutation — changes to the proteins and other components of bacterial cells which Antimicrobial use as binding sites (DRUG INACTIVATION OR MODIFICATION). • Gene transfer: plasmids (via conjugation and transduction); • By bacteria producing enzymes (β-lactamase) that destroy or inactivate Antimicrobial. • Microbes may cease active uptake of certain
  • 40. Resistance to Antibiotics • Changes in receptors which decrease antibiotic binding and action : ALTERATION OF TARGET OR BINDING SITE OF ANTIBIOTICS) • Microbes may synthesize compounds that antagonize drug actions. • By bacteria altering the permeability of their cell membrane making it difficult for Antimicrobial to enter (ACTIVE EFFLUX). • Antibiotic use promotes the emergence of drug-resistant microbes.